Qiagen N.V.: Some Clarity Needed Before Buying The Dip

Group 1 - The article highlights the focus on Qiagen N.V. (NYSE: QGEN), a mid-cap company in the medical diagnostic industry with a market capitalization exceeding $8 billion [2] - Qiagen is noted for receiving relatively little coverage in the United States, which may be attributed to its headquarters location [2] - The Biotech Forum, led by Bret, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat discussions and weekly research updates [2]